Back to results
US 2010/0144759 A1Published application
Novel n-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor ccr4
AssigneeAstraZeneca AB
InventorsDavid CHESHIRE, Nicholas Kindon, Antonio Mete, Bryan Roberts
Life of this patent
Estimating the term…
Abstract
The invention provides N-(fluoro-pyrazinyl)-phenylsulfonamides of formula (I) wherein R1-R5 are as defined in the specification; processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy
Claims7
1-6. (canceled)
The compound
- 2,3-Dichloro-N-(5-fluoro-3-methoxypyrazin-2-yl)-benzenesulfonamide,
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising a compound as claimed in claim 1, or a pharmaceutically acceptable salt thereof, association with a pharmaceutically acceptable adjuvant, diluent or carrier.
9-10. (canceled)
13-14. (canceled)
Dependencies are inferred from the claim text.